The Accornero Lab aims at understanding the mechanisms underlying heart and skeletal muscle diseases with the goal of developing new therapeutic strategies for myopathies. The group is particularly interested in targeting RNA-binding proteins to modulate the expression of pathologic genes during stress challenges.